These data would suggest that JAK inhibition could lead to a reduction in the accumulation of CD8+ lymphocytes in COPD, however other chemokines and receptors, possibly CCR5 which is also expressed on these cells [3, 30] could provide an alternative avenue for cell migration and activation. This evidence concerns the gene CCR5 and chronic obstructive pulmonary disease.